ArticleBMC neurology2025
Tirofiban-induced acute profound thrombocytopenia in endovascular therapy for acute ischemic stroke: a rare case report.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStudies have shown that tirofiban (a glycoprotein IIb/IIIa receptor antagonist) is effective in the endovascular treatment of cerebrovascular diseases. However, it has also been reported that tirofiban can cause thrombocytopenia. Here we report a rare case of tirofiban-induced acute profound thrombocytopenia in a patient undergoing endovascular therapy for acute ischemic stroke. CASE REPORT: A 39-year-old male patient was sent to the emergency department of our hospital due to a sudden onset of disturbance in consciousness, aphasia and right hemiparesis for 2 h. Computed tomography angiogram (CTA) revealed an occlusion of the left middle cerebral artery. He was directed into emergency embolectomy with stent implantation under digital subtraction angiography (DSA) guidance. Due to the extensive clot formation during surgery, a bolus of 20 ml tirofiban was slowly injected through the guiding catheter. Approximately two hours after the infusion, the patient developed acute profound thrombocytopenia.
conclusionTirofiban-induced thrombocytopenia after drug infusion may occur acutely and without any bleeding manifestations. There may be a clinical correlation between the loading dose of tirofiban and the occurrence of acute profound thrombocytopenia. Clinicians should maintain high caution for the potential crash of platelet levels when this drug is administered during procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.